Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in SPRB — Spruce Biosciences, Inc.

CIK 886982 NEW YORK, NY
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,746,792
+$1,386,975 QoQ
Shares Held
32,348
+487.5% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 63 holders
Holding Since
Mar 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. SPRB ranks #232 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in SPRB

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,746,792 32,348
2026-03-31 $359,817 5,506
2023-03-31 $403,669 182,656
2022-09-30 $26,787 19,553
2022-06-30 $103,719 59,609
2022-03-31 $85,762 42,668
2021-12-31 $1,029,372 230,801
2021-09-30 $77,865 12,956
2021-06-30 $120,731 10,770
2021-03-31 $206,620 12,447